Eban describes the aftermath of the Ranbaxy case. Peter Baker, Thakur, and others who investigated generic drugs continued to avoid generics in their own lives and advised others to do the same. Thakur and Sonal were not able to repair their marriage and eventually divorced. Peter Baker relocated to China, and uncovered similar operations to the ones he observed in India: secondary manufacturing operations that tested and manufactured drugs in parallel to the official pharmaceutical facilities.

The Ranbaxy company no longer exists, and Daiichi Sankyo won its case against Malvinder Singh.

The FDA continued to find issues with Mylan’s plants.

After Lal was removed from his position at the FDA, the FDA resumed its previous method of inspections: announcing them in advance.